NASDAQ:QDEL QuidelOrtho - QDEL Stock Forecast, Price & News Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding QuidelOrtho Co. Please log in to your account or sign up in order to add this asset to your watchlist. $89.70 -1.76 (-1.92%) (As of 02/3/2023 12:00 AM ET) Add Compare Share Share Today's Range$89.44▼$92.0050-Day Range$81.53▼$97.5052-Week Range$66.88▼$120.61Volume394,125 shsAverage Volume509,965 shsMarket Capitalization$5.92 billionP/E Ratio4.77Dividend YieldN/APrice Target$122.00 ProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial MediaSustainability QuidelOrtho MarketRank™ ForecastAnalyst RatingModerate Buy2.80 Rating ScoreUpside/Downside36.0% Upside$122.00 Price TargetShort InterestBearish5.10% of Shares Sold ShortDividend StrengthN/ASustainability-2.61Upright™ Environmental ScoreNews Sentiment0.92Based on 4 Articles This WeekInsider TradingN/AProj. Earnings Growth-62.06%From $13.23 to $5.02 Per ShareSee Full Details Hide Full Details Overall MarketRank™MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.2.13 out of 5 starsMedical Sector366th out of 1,028 stocksDiagnostic Substances Industry6th out of 15 stocks 3.4 Analyst's Opinion Consensus RatingQuidelOrtho has received a consensus rating of Buy. The company's average rating score is 2.80, and is based on 2 buy ratings, 2 hold ratings, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $122.00, QuidelOrtho has a forecasted upside of 36.0% from its current price of $89.70.Amount of Analyst CoverageQuidelOrtho has only been the subject of 2 research reports in the past 90 days. Previous Next 1.0 Short Interest Percentage of Shares Shorted5.10% of the outstanding shares of QuidelOrtho have been sold short.Short Interest Ratio / Days to CoverQuidelOrtho has a short interest ratio ("days to cover") of 5.3.Change versus previous monthShort interest in QuidelOrtho has recently increased by 13.47%, indicating that investor sentiment is decreasing significantly. Previous Next 0.0 Dividend Strength Dividend YieldQuidelOrtho does not currently pay a dividend.Dividend GrowthQuidelOrtho does not have a long track record of dividend growth. Previous Next 3.8 Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreQuidelOrtho has received a 49.48% net impact score from Upright. The largest positive contribution comes from its "Physical diseases" impact, which is mostly driven by its "Sexually transmitted diseases quick tests", "Lactose intolerance quick tests", and "Respiratory tract infection tests" products. See details.Environmental SustainabilityThe Environmental Impact score for QuidelOrtho is -2.61. Previous Next 2.2 News and Social Media Coverage News SentimentQuidelOrtho has a news sentiment score of 0.92. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.47 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 4 news articles for QuidelOrtho this week, compared to 4 articles on an average week.Search InterestOnly 9 people have searched for QDEL on MarketBeat in the last 30 days. This is a decrease of -44% compared to the previous 30 days. Previous Next 1.7 Company Ownership Insider Buying vs. Insider SellingIn the past three months, QuidelOrtho insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 2.70% of the stock of QuidelOrtho is held by insiders.Percentage Held by Institutions95.21% of the stock of QuidelOrtho is held by institutions. High institutional ownership can be a signal of strong market trust in this company. Previous Next 1.3 Earnings and Valuation Earnings GrowthEarnings for QuidelOrtho are expected to decrease by -62.06% in the coming year, from $13.23 to $5.02 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of QuidelOrtho is 4.77, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 129.86.Price to Earnings Ratio vs. SectorThe P/E ratio of QuidelOrtho is 4.77, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 86.85.Price to Book Value per Share RatioQuidelOrtho has a P/B Ratio of 1.94. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here About QuidelOrtho (NASDAQ:QDEL) StockQuidelOrtho Corp. operates as a vitro diagnostics company. It is focused on developing and manufacturing diagnostic products. The company was founded on May 27, 2022 and is headquartered in San Diego, CA.Read More Receive QDEL Stock News and Ratings via Email Sign-up to receive the latest news and ratings for QuidelOrtho and its competitors with MarketBeat's FREE daily newsletter. Email Address QDEL Stock News HeadlinesJanuary 6, 2023 | finance.yahoo.comQuidelOrtho Reports Preliminary Revenue Results for Fourth Quarter and Full Year 2022January 3, 2023 | finance.yahoo.comIs QuidelOrtho Corporation's (NASDAQ:QDEL) Latest Stock Performance A Reflection Of Its Financial Health?February 5, 2023 | Investor Place Media (Ad)Cash Holders STILL Aren't Taking Steps to PrepareStocks are crashing... inflation is through the roof... multiple industries are getting hit hard... Americans are fearful of what might happen to their stock portfolios right now -- and who's to blame them? But former Wall Street money manager Louis Navellier says all it takes is being on the right side of this force driving the massive divide. Take action today and watch his exclusive presentation -- absolutely free of charge -- to see how you should be prepping for this phenomenon.December 28, 2022 | finance.yahoo.comQuidelOrtho to Present at the J.P. Morgan Healthcare ConferenceDecember 20, 2022 | finance.yahoo.comQuidelOrtho's (QDEL) Myocardial Infarction Test Cleared in CanadaDecember 16, 2022 | finance.yahoo.comQuidelOrtho and Runda Medical Form Joint Venture to Develop and Manufacture Assays for VITROS® PlatformDecember 12, 2022 | finance.yahoo.comQuidelOrtho Announces Separation of Chairman and Chief Executive Officer RolesDecember 8, 2022 | finance.yahoo.comShould You Invest in QuidelOrtho Corporation (QDEL) for a Long-Term Advantage?February 5, 2023 | Investor Place Media (Ad)Cash Holders STILL Aren't Taking Steps to PrepareStocks are crashing... inflation is through the roof... multiple industries are getting hit hard... Americans are fearful of what might happen to their stock portfolios right now -- and who's to blame them? But former Wall Street money manager Louis Navellier says all it takes is being on the right side of this force driving the massive divide. Take action today and watch his exclusive presentation -- absolutely free of charge -- to see how you should be prepping for this phenomenon.December 3, 2022 | nasdaq.comQuidelOrtho (QDEL) Crossed Above the 20-Day Moving Average: What That Means for InvestorsNovember 30, 2022 | finance.yahoo.comQuidelOrtho to Host Investor Day on December 13, 2022November 8, 2022 | finance.yahoo.comWill the Demand for QuidelOrtho Corporation (QDEL)’s Products Increase in Near Term?November 2, 2022 | finance.yahoo.comQuidelOrtho Reports Third Quarter 2022 Financial ResultsOctober 19, 2022 | finance.yahoo.comAre Investors Undervaluing QuidelOrtho Corporation (NASDAQ:QDEL) By 49%?October 18, 2022 | investing.com5 Potentially Undervalued Pharma Companies - Investing.comOctober 14, 2022 | finance.yahoo.comThese 10 Stocks are Gaining Today - Yahoo FinanceOctober 14, 2022 | rttnews.comPre-market Movers: KNTE, PUMP, SSNT, DWAC, LLAP… - RTTNewsOctober 13, 2022 | washingtonpost.comDomino's, Duck Creek rise; Relmada, A.O. Smith fall - The Washington PostOctober 13, 2022 | seekingalpha.comQuidelOrtho forecasts strong Q3 revenue above estimates, shares rise ~6% after hours - Seeking AlphaOctober 13, 2022 | seekingalpha.comVectivBio, QuidelOrtho top healthcare gainers; Relmada, T2 Biosystems lead losers' pack - Seeking AlphaOctober 12, 2022 | investing.comAfter-Hours Movers: DWAC Up as Truth Approved for Google Play, AMAT Falls on Lower Outlook By Investing.com - Investing.comOctober 12, 2022 | businesswire.comQuidelOrtho Reports Preliminary Revenue Results for Third Quarter 2022 - Business WireOctober 12, 2022 | finance.yahoo.comQuidelOrtho Reports Preliminary Revenue Results for Third Quarter 2022October 6, 2022 | reuters.comQDEL.P - Quidelortho Corp | Stock Price & Latest News | ReutersSeptember 29, 2022 | reuters.comQDEL.OQ - Quidelortho Corp | Stock Price & Latest News | ReutersSeptember 27, 2022 | benzinga.comStocks That Hit 52-Week Lows On Tuesday - Universal Insurance Hldgs (NYSE:UVE), Visa (NYSE:V) - BenzingaSeptember 26, 2022 | benzinga.com5 Value Stocks To Watch In The Healthcare Sector - Graphite Bio (NASDAQ:GRPH), Baudax Bio (NASDAQ:BXRX), - BenzingaSee More Headlines View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart Receive QDEL Stock News and Ratings via Email Sign-up to receive the latest news and ratings for QuidelOrtho and its competitors with MarketBeat's FREE daily newsletter. Email Address QDEL Company Calendar Last Earnings11/04/2021Today2/05/2023Next Earnings (Confirmed)2/15/2023Fiscal Year End12/31/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ Industry Diagnostic substances Sub-IndustryHealth Care Supplies SectorMedical Current SymbolNASDAQ:QDEL CUSIP74838J10 CIK353569 Webwww.quidel.com Phone(800) 874-1517Fax858-453-4338Employees1,600Year Founded1979Price Target and Rating Average Stock Price Forecast$122.00 High Stock Price Forecast$173.00 Low Stock Price Forecast$86.00 Forecasted Upside/Downside+36.0%Consensus RatingModerate Buy Rating Score (0-4)2.80 Research Coverage5 Analysts Profitability EPS (Most Recent Fiscal Year)$18.80 Trailing P/E Ratio4.77 Forward P/E Ratio6.78 P/E GrowthN/ANet Income$704.23 million Net Margins26.67% Pretax Margin35.25% Return on Equity30.18% Return on Assets18.45% Debt Debt-to-Equity Ratio0.52 Current Ratio1.66 Quick Ratio1.04 Sales & Book Value Annual Sales$1.70 billion Price / Sales3.49 Cash Flow$19.17 per share Price / Cash Flow4.68 Book Value$46.30 per share Price / Book1.94Miscellaneous Outstanding Shares66,040,000Free Float64,262,000Market Cap$5.92 billion OptionableOptionable Beta0.27 Social Links Key ExecutivesDouglas C. BryantPresident, Chief Executive Officer & DirectorRobert Joseph BujarskiChief Operating Officer & Executive Vice PresidentJoseph Michael BuskyChief Financial OfficerWerner KrollSenior Vice President-Research & DevelopmentMichael S. IskraChief Commercial Officer & Executive VPKey CompetitorsNeogenNASDAQ:NEOGMeridian BioscienceNASDAQ:VIVOLantheusNASDAQ:LNTHIntellia TherapeuticsNASDAQ:NTLACelldex TherapeuticsNASDAQ:CLDXView All CompetitorsInsiders & InstitutionsCannell & Co.Sold 535 shares on 2/3/2023Ownership: 0.352%Private Management Group Inc.Sold 30,564 shares on 2/3/2023Ownership: 0.203%Larson Financial Group LLCBought 20,614 shares on 2/3/2023Ownership: 0.031%Aurora Investment CounselSold 2,475 shares on 2/3/2023Ownership: 0.015%Mendota Financial Group LLCBought 1,131 shares on 2/3/2023Ownership: 0.002%View All Insider TransactionsView All Institutional Transactions QDEL Stock - Frequently Asked Questions Should I buy or sell QuidelOrtho stock right now? 5 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for QuidelOrtho in the last year. There are currently 2 hold ratings, 2 buy ratings and 1 strong buy rating for the stock. The consensus among Wall Street research analysts is that investors should "buy" QDEL shares. View QDEL analyst ratings or view top-rated stocks. What is QuidelOrtho's stock price forecast for 2023? 5 brokers have issued 1 year price targets for QuidelOrtho's stock. Their QDEL share price forecasts range from $86.00 to $173.00. On average, they expect the company's share price to reach $122.00 in the next year. This suggests a possible upside of 36.0% from the stock's current price. View analysts price targets for QDEL or view top-rated stocks among Wall Street analysts. How have QDEL shares performed in 2023? QuidelOrtho's stock was trading at $85.67 on January 1st, 2023. Since then, QDEL stock has increased by 4.7% and is now trading at $89.70. View the best growth stocks for 2023 here. When is QuidelOrtho's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Wednesday, February 15th 2023. View our QDEL earnings forecast. How can I listen to QuidelOrtho's earnings call? QuidelOrtho will be holding an earnings conference call on Wednesday, February 15th at 5:00 PM Eastern. Interested parties can register for or listen to the call using this link. How were QuidelOrtho's earnings last quarter? QuidelOrtho Co. (NASDAQ:QDEL) announced its quarterly earnings results on Thursday, November, 4th. The company reported $5.36 earnings per share (EPS) for the quarter, topping the consensus estimate of $3.52 by $1.84. The company earned $509.70 million during the quarter, compared to analysts' expectations of $344.25 million. QuidelOrtho had a trailing twelve-month return on equity of 30.18% and a net margin of 26.67%. The business's revenue for the quarter was up 7.1% on a year-over-year basis. During the same period in the prior year, the firm earned $5.68 earnings per share. What guidance has QuidelOrtho issued on next quarter's earnings? QuidelOrtho updated its FY 2022 earnings guidance on Wednesday, February, 1st. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $4.04 billion-$4.05 billion, compared to the consensus revenue estimate of $3.23 billion. What is Doug Bryant's approval rating as QuidelOrtho's CEO? 47 employees have rated QuidelOrtho Chief Executive Officer Doug Bryant on Glassdoor.com. Doug Bryant has an approval rating of 76% among the company's employees. What other stocks do shareholders of QuidelOrtho own? Based on aggregate information from My MarketBeat watchlists, some companies that other QuidelOrtho investors own include NVIDIA (NVDA), DocuSign (DOCU), Tesla (TSLA), PayPal (PYPL), Shopify (SHOP), Block (SQ), Teladoc Health (TDOC), Netflix (NFLX), Advanced Micro Devices (AMD) and Zoom Video Communications (ZM). What is QuidelOrtho's stock symbol? QuidelOrtho trades on the NASDAQ under the ticker symbol "QDEL." Who are QuidelOrtho's major shareholders? QuidelOrtho's stock is owned by a number of retail and institutional investors. Top institutional shareholders include LGT Capital Partners LTD. (0.95%), Cannell & Co. (0.35%), New York State Common Retirement Fund (0.25%), Allspring Global Investments Holdings LLC (0.24%), Wedge Capital Management L L P NC (0.23%) and Private Management Group Inc. (0.20%). Insiders that own company stock include Charles P Slacik, Douglas C Bryant, Edward Keith Russell, Edward L Michael, Mary Lake Ph D Polan, Matthew Strobeck, Michael Donald Jr Abney, Randall J Steward, Ratan S Borkar, Robert Joseph Bujarski, Werner Kroll, William J Ferenczy and William J Ferenczy. View institutional ownership trends. How do I buy shares of QuidelOrtho? Shares of QDEL stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is QuidelOrtho's stock price today? One share of QDEL stock can currently be purchased for approximately $89.70. How much money does QuidelOrtho make? QuidelOrtho (NASDAQ:QDEL) has a market capitalization of $5.92 billion and generates $1.70 billion in revenue each year. The company earns $704.23 million in net income (profit) each year or $18.80 on an earnings per share basis. How many employees does QuidelOrtho have? The company employs 1,600 workers across the globe. How can I contact QuidelOrtho? QuidelOrtho's mailing address is 9975 SUMMERS RIDGE ROAD, SAN DIEGO CA, 92121. The official website for the company is www.quidel.com. The company can be reached via phone at (800) 874-1517, via email at rargueta@quidel.com, or via fax at 858-453-4338. This page (NASDAQ:QDEL) was last updated on 2/5/2023 by MarketBeat.com Staff Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.